FANTIN, Martina
 Distribuzione geografica
Continente #
NA - Nord America 904
EU - Europa 222
AS - Asia 139
SA - Sud America 1
Totale 1.266
Nazione #
US - Stati Uniti d'America 902
CN - Cina 97
UA - Ucraina 67
DE - Germania 44
GB - Regno Unito 36
IT - Italia 35
TR - Turchia 27
SE - Svezia 17
FI - Finlandia 14
SG - Singapore 11
FR - Francia 5
BE - Belgio 2
CA - Canada 2
CL - Cile 1
CZ - Repubblica Ceca 1
IN - India 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
Totale 1.266
Città #
Fairfield 117
Woodbridge 116
Chandler 81
Ann Arbor 79
Jacksonville 76
Houston 71
Ashburn 54
Seattle 45
Wilmington 42
Cambridge 39
Beijing 24
Izmir 21
Nanjing 21
Milan 16
Princeton 16
Bremen 14
Shanghai 13
Boardman 11
San Diego 11
Falls Church 10
Singapore 8
Jiaxing 7
New York 7
Auburn Hills 6
Hebei 5
Ferrara 4
Jinan 4
San Mateo 4
Shenyang 4
Tianjin 4
Dearborn 3
London 3
Los Angeles 3
Ningbo 3
Norwalk 3
Brussels 2
Changsha 2
Des Moines 2
Fuzhou 2
Mountain View 2
Nanchang 2
Ottawa 2
Redwood City 2
Taizhou 2
Verona 2
Amritsar 1
Brno 1
Changchun 1
Chicago 1
Clearwater 1
Coyhaique 1
Hangzhou 1
Kista 1
La Canada Flintridge 1
New Bedfont 1
Philadelphia 1
San Francisco 1
Springfield 1
Tappahannock 1
Tokyo 1
Walnut 1
Washington 1
Zhengzhou 1
Totale 983
Nome #
Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic G i/o protein linked pathways 117
NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid 116
null 113
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 113
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism 106
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 106
Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease 100
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 95
null 87
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 74
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 61
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 56
Differential regulation of striato-nigral and striato-pallidal pathways by striatal NR2A and NR2B subunit containing receptors 54
NR2A and NR2B Subunit Selective NMDA antagonists improve motor performance and reduce pallidal GABA release in 6-OHDA hemilesioned rats 50
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine 19
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways 9
Totale 1.276
Categoria #
all - tutte 4.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 46 8 16 40 16 31 25 27 20 24 26 8
2020/2021197 14 17 9 22 20 16 1 32 0 22 23 21
2021/2022147 5 21 12 7 3 10 10 4 5 9 15 46
2022/2023190 18 5 16 18 41 24 16 16 27 0 5 4
2023/202459 9 6 4 3 1 11 2 4 2 1 0 16
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.276